aNAAT	Automated nucleic acid amplification test
AUC	Area under the curve
BALF	Bronchoalveolar lavage fluid
BDQ	Bedaquiline
CAPAs	Corrective and preventive actions
CFZ	Clofazimine
CrI	Credible interval
DALY	Disability-adjusted life year
DR-TB	Drug-resistant tuberculosis
DST	Drug susceptibility testing
dUTP	Deoxyuridine triphosphate
EHR	Electronic health record
ENA	European Nucleotide Archive
EQA	External quality assessment
FN	False negative
FP	False positive
FQ	Fluoroquinolone
GA4GH	Global Alliance for Genomics and Health
GLI	Global Laboratory Initiative
ICER	Incremental cost-effectiveness ratio
INSDC	International Nucleotide Sequence Database Collaboration
KPI	Key performance indicator
LIMS	Laboratory information management system
LoD	Limit of detection
LoQ	Limit of quantitation
LPA	Line probe assay
LZD	Linezolid
NPA	Negative percent agreement
NPV	Negative predictive value
MIC	Minimum inhibitory concentration
MTB	Mycobacterium tuberculosis
MTBC	Mycobacterium tuberculosis complex
NIAID	National Institute of Allergy and Infectious Diseases
NTC	Non-template control
NTM	Nontuberculous mycobacteria
ONT	Oxford Nanopore Technologies
OPA	Overall percent agreement
pDST	Phenotypic drug susceptibility testing
PPA	Positive percent agreement
PPV	Positive predictive value
QA	Quality assurance
QRDR	Quinolone resistance-determining region
RACI	Responsible, accountable, consulted, and informed
RRDR	Rifampicin resistance-determining region
SNP	Single-nucleotide polymorphism
SNV	Single-nucleotide variant
SOP	Standard operating procedure
SRA	Sequence Read Archive
TAT	Turnaround time
TB	Tuberculosis
TDM	Therapeutic drug monitoring
Tm	Melting temperature
TN	True negative
TP	True positive
tNGS	Targeted next-generation sequencing
UMI	Unique molecular identifier
UNG	Uracil-DNA glycosylase
VAF	Variant allele frequency
VUS	Variant of uncertain significance
WGS	Whole-genome sequencing
WHO	World Health Organization
WTP	Willingness to pay